AgeX Therapeutics Inc. (AGE)
AMEX: AGE
· Real-Time Price · USD
11.10
-1.50 (-11.90%)
At close: Mar 26, 2024, 8:59 PM
AgeX Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | -51K | 14K | 51K | 5K | 56K | 46K | 9K | 10K | 8K | 9K | 12K | 5K | 27K | 24K | 37K | 56K |
Cost of Revenue | n/a | 67K | n/a | n/a | n/a | 34K | 33K | 5K | 1K | 1K | 5K | 6K | 1K | 1K | 2K | 13K | 3K |
Gross Profit | n/a | -40K | n/a | n/a | 5K | 22K | 13K | 4K | 9K | 7K | 4K | 6K | 4K | 26K | 22K | 24K | 53K |
Operating Income | -5.86M | -8.81M | -5.31M | -3.87M | -2.32M | -3.56M | -2.36M | -1.89M | -2.16M | -1.78M | -1.55M | -1.59M | -2.05M | -1.87M | -1.67M | -2.21M | -2.29M |
Interest Income | n/a | -28K | n/a | n/a | n/a | 28K | n/a | 792K | 1.1M | 978K | 923K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -4.81M | 7.14M | 1.41M | 5.2M | -9.44M | -3.46M | -5.39M | -2.68M | -3.29M | -2.76M | -2.44M | -2.62M | -2.71M | -2.16M | -1.96M | -2.48M | -1.99M |
Net Income | -4.81M | 7.15M | 1.41M | 5.2M | -9.44M | -3.46M | -5.4M | -2.67M | -5.5M | -2.7M | -3.32M | -3.65M | -3.36M | -2.16M | -1.96M | -2.47M | -2.09M |
Selling & General & Admin | 2.91M | 2.8M | 2.91M | 2.32M | 1.22M | 3.43M | 2.17M | 1.73M | 1.99M | 1.58M | 1.39M | 1.34M | 1.66M | 1.52M | 1.42M | 1.75M | 2.02M |
Research & Development | 2.95M | 6.01M | 2.42M | 1.59M | 1.11M | 149K | 218K | 160K | 174K | 208K | 162K | 259K | 396K | 376K | 275K | 481K | 324K |
Other Expenses | n/a | -4K | n/a | n/a | n/a | 1K | n/a | 4K | 3K | 4K | 2K | 4K | n/a | 3K | 4K | 4K | n/a |
Operating Expenses | 5.86M | 8.81M | 5.33M | 3.92M | 2.33M | 3.58M | 2.37M | 1.89M | 2.17M | 1.79M | 1.55M | 1.6M | 2.06M | 1.89M | 1.7M | 2.23M | 2.35M |
Interest Expense | n/a | -3.46M | -16K | -242K | -99K | n/a | 3.04M | 792K | 1.1M | 978K | 923K | 863K | 571K | 295K | 285K | 274K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 8.87M | n/a | n/a | 2.33M | 3.62M | 2.4M | 1.9M | 2.17M | 1.79M | 1.56M | 1.6M | 2.06M | 1.89M | 1.7M | 2.24M | 2.35M |
Income Tax Expense | n/a | -3.05M | n/a | n/a | n/a | -2K | 3.05M | 786K | 2.22M | -57K | 885K | 1.03M | 654K | -10K | n/a | 277K | 232K |
Shares Outstanding (Basic) | 9.76M | 7.36M | 8.85M | 8.51M | 4.8M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.07M |
Shares Outstanding (Diluted) | 9.76M | 7.36M | 10.75M | 10.16M | 5.62M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.07M |
EPS (Basic) | -0.49 | 10.08 | 0.16 | 0.61 | -1.97 | -3.2 | -5.01 | -2.47 | -5.1 | -2.51 | -3.08 | -3.38 | -3.12 | -2 | -1.81 | -2.29 | -1.95 |
EPS (Diluted) | -0.49 | 10.08 | 0.13 | 0.51 | -1.68 | -3.2 | -5.01 | -2.47 | -5.1 | -2.51 | -3.08 | -3.38 | -3.12 | -2 | -1.81 | -2.29 | -1.95 |
EBITDA | -5.86M | 550K | -5.31M | -3.87M | -2.32M | -3.53M | -2.32M | -1.85M | -2.16M | -1.75M | -1.51M | -1.55M | -2.1M | -1.83M | -1.64M | -2.17M | -2.37M |
EBIT | n/a | 15.4M | n/a | n/a | -9.54M | -3.51M | -2.35M | -1.89M | -2.19M | -1.78M | -1.51M | -1.75M | -2.14M | -1.86M | -1.67M | -2.2M | -4.18M |
Depreciation & Amortization | n/a | -91K | n/a | n/a | 25K | 33K | 33K | 32K | 36K | 37K | 35K | 37K | -51K | 33K | 32K | 33K | 33K |